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Abstract. 
 
We have identiﬁed a 
 
Dictyostelium
 
 
 
discoi-
deum 
 
gene encoding a serine/threonine kinase, PAKa, a 
putative member of the Ste20/PAK family of p21-acti-
vated kinases, with a kinase domain and a long NH
 
2
 
-
terminal regulatory domain containing an acidic seg-
ment, a polyproline domain, and a CRIB domain. 
PAKa colocalizes with myosin II to the cleavage furrow 
of dividing cells and the posterior of polarized, chemo-
taxing cells via its NH
 
2
 
-terminal domain. 
 
paka
 
 null cells 
are defective in completing cytokinesis in suspension. 
PAKa is also required for maintaining the direction of 
cell movement, suppressing lateral pseudopod exten-
sion, and proper retraction of the posterior of chemo-
taxing cells. 
 
paka
 
 null cells are defective in myosin II
assembly, as the myosin II cap in the posterior of 
chemotaxing cells and myosin II assembly into cyto-
skeleton upon cAMP stimulation are absent in these 
cells, while constitutively active PAKa leads to an up-
regulation of myosin II assembly. PAKa kinase activity 
against histone 2B is transiently stimulated and PAKa 
incorporates into the cytoskeleton with kinetics similar 
to those of myosin II assembly in response to chemoat-
tractant signaling. However, PAKa does not phosphor-
ylate myosin II. We suggest that PAKa is a major regu-
lator of myosin II assembly, but does so by negatively 
regulating myosin II heavy chain kinase.
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T
 
HE
 
 actin cytoskeleton, composed of actin filaments
and multiple actin-binding proteins, plays important
roles in cell motility, cytokinesis, phagocytosis, and
probably intracellular transport processes (Cooper, 1991;
Mabuchi, 1994). Cell movement requires the protrusive
and contractile forces generated via polymerization, depo-
lymerization, and cross-linking of actin filaments and myo-
sin motors. The Rho family of small G proteins are key
regulators of changes in the actin cytoskeleton (Nobes et al.,
1995; Tapon and Hall, 1997; Hall, 1998). In yeast, Cdc42 is
required for cell polarization and bud formation (Ziman
et al., 1993; Kron and Gow, 1995; Li et al., 1995), whereas
a mutation in a putative Rac exchange factor leads to cell
polarization defects during 
 
Drosophila
 
 
 
melanogaste
 
r em-
bryogenesis (Häcker and Perrimon, 1998). In mammalian
cells, Cdc42 regulates the formation of filopodia, whereas
Rac regulates lamellipodia formation and membrane ruf-
fling, and RhoA regulates the formation of stress fibers.
These pathways can be regulated through growth factor
signaling and are important in controlling cellular move-
ment and differentiation.
Conventional myosin (myosin II) is a key component in
the regulation of cell motility, cytokinesis, and phagocyto-
sis, functioning as an essential force-generating motor in
these processes (Spudich et al., 1995). Myosin II localizes
to the contractile ring (cleavage furrow) during cytokinesis
of metazoan and 
 
Dictyostelium
 
 
 
discoideum 
 
cells (Fukui,
1990; Otto and Schroeder, 1990; Moores et al., 1996). In
 
Dictyostelium
 
, myosin II (
 
myoII
 
) null cells show a condi-
tional growth phenotype: the cells cannot undergo cytoki-
nesis in suspension and form large, multinucleated cells
(De Lozanne and Spudich, 1987; Knecht and Loomis,
1988). However, when grown on a substratum, the cells
cleave by traction-mediated cytokinesis (Fukui et al.,
1990). Myosin II is also involved in the regulation of
chemotaxis. In polarized, chemotaxing cells, myosin II is
predominantly localized to the posterior of the cell and
forms a C-shaped cap that contracts during the last stage
of cell movement, causing the posterior of the cell to de-
tach from the substratum and move forward (Moores et
al., 1996; Clow and McNally, 1999). Wild-type cells pre-
dominantly form a single pseudopod at the leading edge;
 
myoII
 
 null cells produce lateral pseudopodia, possibly due
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to reduced cortical tension (Pasternak et al., 1989) and
have difficulty lifting the cell’s posterior (Jay et al., 1995).
This leads to a slower and less efficient chemotaxis.
Other key regulators of the cytoskeleton are PAKs, p21-
activated Ser/Thr protein kinases, which are thought to lie
downstream of Rac and Cdc42. The first members of this
kinase family to be identified were Ste20 and Cla4 from
 
Saccharomyces cerevisiae
 
, which are regulated by Cdc42
(Herskowitz, 1995). Members of the PAK family have an
NH
 
2
 
-terminal regulatory domain that contains a CRIB
(Cdc42/Rac binding) domain and a related COOH-termi-
nal kinase domain. Mammalian p
 
65
 
PAK can be activated
via autophosphorylation in vitro upon the binding of acti-
vated (GTP-bound) Rho family members, Cdc42 and Rac
(Manser et al., 1994). The yeast PAK, Ste20, plays im-
portant roles in activating the MAP kinase cascade in
the pheromone-response pathway (Herskowitz, 1995), al-
though mammalian PAKs have been implicated in the ac-
tivation of the Rac/Cdc42-regulated MAP kinase cascades
leading to the stimulation of stress-induced MAP kinases
p38 and JNK (Bagrodia et al., 1995; Zhang et al., 1995).
There is increasing evidence that PAK family kinases
regulate cytoskeletal changes mediated by Cdc42 and Rac.
Ste20, along with its homologue Cla4, regulates polarized
cell growth, presumably by controlling the actin cytoskele-
ton (Chant and Stowers, 1995; Cvrckova et al., 1995). Mi-
croinjection of activated PAK1 protein into quiescent
Swiss 3T3 cells induces the rapid formation of lamellipo-
dia, filopodia, and membrane ruffles (Sells et al., 1997),
which is very similar to the effect produced by microinjec-
tion of activated Rac and Cdc42 (Nobes and Hall, 1995).
Moreover, the 
 
Drosophila
 
 homologue of mammalian
PAK1 is a key regulator of the cytoskeletal changes re-
quired for axonal guidance (Hing et al., 1999). Expression
of various constitutively active forms of 
 
a
 
PAK induces
disassembly of stress fibers and focal adhesion complexes
(Manser et al., 1997). A 
 
Dictyostelium 
 
myosin I heavy
chain kinase (MIHCK)
 
1
 
 homologous to PAK and Ste20
has been cloned and proposed to provide a direct link be-
tween Cdc42/Rac signaling pathways and motile processes
requiring myosin I molecules (Lee et al., 1996; Brzeska
et al., 1997). PAKs also appear to regulate the function of
myosin II, as the regulatory myosin light chains are phos-
phorylated by the Jurkat and placenta 
 
g
 
PAK (Ramos et al.,
1997), suggesting that different PAKs may regulate differ-
ent cytoskeletal components.
We describe the properties of a putative 
 
Dictyostelium
 
PAK (PAKa) that contains a potential polyproline SH3
binding domain, a highly acidic domain in its NH
 
2
 
 termi-
nus, a CRIB domain, and a related kinase domain. 
 
paka
 
null cells or wild-type cells expressing a kinase dead (puta-
tive dominant negative) PAKa produce many random, lat-
eral pseudopodia and have a much higher frequency of
making wrong turns than wild-type cells. Similarities in the
distributions of PAKa
 
 
 
and myosin II and in the pheno-
 
types of 
 
paka
 
 and 
 
myoII
 
 null cells suggest that PAKa
might be involved in the regulation of myosin II filament
assembly in the posterior cortex. Furthermore, the in-
crease of myosin II in the cytoskeleton in wild-type cells in
response to cAMP was lacking in 
 
paka
 
 null cells, suggest-
ing the assembly of myosin II into the cytoskeleton re-
quires PAKa function. PAKa kinase is activated in re-
sponse to stimulation with the chemoattractant cAMP,
suggesting it controls chemotaxis by regulating myosin II
function.
 
Materials and Methods
 
Materials
 
Sodium orthovanadate, 
 
b
 
-glycerophosphate, aprotinin, and leupeptin
were obtained from Sigma Chemical Co. Histone 2B was purchased
from Boehringer Mannheim Corp. 
 
g
 
[
 
32
 
P]ATP was from ICN Biomedi-
cals. Protein A–Sepharose CL-4B was obtained from Pharmacia Biotech
Inc. Purified myosin II was a generous gift from Dr. Tom Egelhoff (Case
Western Reserve University, Cleveland, OH).
 
Cloning of PAKa
 
To clone PAKa, a pair of degenerate primers was made based on the
amino acid sequences conserved among the kinase domains of yeast Ste20
and human PAK65 (the two primers corresponded to the amino acid se-
quences VAIKK and DFGLAR). A full-length cDNA clone (3.6 kb) was
obtained by screening a 12–16 h developmental 
 
l
 
ZAP library with a
probe amplified by PCR. PAKa was disrupted in the thymidine auxotroph
JH10 by inserting the Thy gene cassette into codon 791, and transformants
were selected. For overexpression experiments, PAKa and PAKa mutants
were subcloned into the DIP-J expression vector (Gaskins et al., 1996).
PAKa was tagged at the COOH terminus with the FLAG epitope by
using primer 5
 
9
 
-TTACTTGTCATCGTCGTCCTTGTATTGTGCAGT-
TAAATTTTGTAATTG-3
 
9
 
. The HA epitope tag was added to the NH
 
2
 
terminus of PAKa by using primer 5
 
9
 
-AAAATGACCTACCCATA-
CGATGTTCCAGATTACGCTGAAGAGAAACCAAAAAGTACA-
ACTCCACCA-3
 
9
 
. 
 
myr
 
PAKa was obtained by PCR using primer 5
 
9
 
-
ATGGGTTCATCAAAATCAAAACCAAAAGATCCATCACAAC-
GTCGTCGT-3
 
9
 
, a sequence coding for the first 16 amino acids of chicken
c-Src, composed of the myristoylation signal and the basic amino acid
cluster sufficient for stable membrane association.
 
Selection of Clones
 
To select for strains expressing a high level of PAKa, transformants were
selected at 40 
 
m
 
g/ml of G418, which in our hands produces clones that ex-
press encoded proteins at high levels. To select clones that express at a
low level, we selected and maintained cells at 15 
 
m
 
g/ml of G418. Clones
were screened to identify those exhibiting a low level of exogenous PAKa
expression and exhibiting wild-type phenotypes in actin staining.
 
Indirect Immunofluorescence Staining
 
For immunofluorescence staining, cells were starved in 12 mM sodium
phosphate buffer (pH 6.2) for 
 
.
 
5 h and fixed with 4% formaldehyde for 5
min. Cells were permeabilized with 0.5% Triton X-100, washed, and incu-
bated with 1.4 
 
m
 
g/ml anti-FLAG mAb or rabbit anti-HA antibody (1/200
dilution) in PBS containing 0.5% BSA and 0.05% Tween-20 for 1 h. Cells
were washed in 0.5% BSA containing PBS and incubated with FITC-
labeled anti-mouse or anti-rabbit antibodies for 1 h. After washing, cells
were observed with a 60
 
3
 
 oil immersion lens on a Nikon Microphot-FX
microscope. Images were captured with a Photometrics Sensys camera
and IPLAB Spectrum software. Anti-HA antibody was purchased from
Santa Cruz Biotechnology. Monoclonal anti-FLAG antibody was ob-
tained from Kodak. F-actin was stained with FITC-labeled phalloidin
(Sigma Chemical Co.). Rabbit antimyosin II antibody was a generous gift
from Dr. James A. Spudich (Stanford University, Stanford, California).
 
PAKa Kinase Activity Assay
 
Log-phase vegetative cells were washed and resuspended at a density of
 
1. 
 
Abbreviations used in this paper:
 
 GFP, green fluorescent protein; H2B,
histone 2B; MIHCK, myosin I heavy chain kinase; 
 
myr
 
PAKa, a PAKa car-
rying the NH
 
2
 
-terminal myristoylation signal from Src; PAKa
 
CA
 
, a putative
constitutively active PAKa containing only the kinase domain; PAKa
 
DN
 
,
kinase dead, putative dominant, negative mutant of PAKa; PAKa
 
G
 
1
 
K
 
, a
PAKa mutant containing the CRIB and kinase domains. 
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2–3 
 
3
 
 10
 
6 
 
cells/ml in Na/K phosphate buffer and pulsed for 5 h with 30 nM
cAMP every 10 min. The cells were collected by centrifugation and resus-
pended at a density of 2–3 
 
3
 
 10
 
7 
 
cells/ml. The cAMP receptor activity was
downregulated by bubbling air through the cell suspension for 10 min (Ma
et al., 1997). The 200-
 
m
 
l samples were lysed by mixing with an equal vol-
ume of 2
 
3
 
 lysis buffer (50 mM Tris, pH 7.6, at room temperature, 200 mM
NaCl, 20 mM NaF, 2 mM vanadate, 50 mM 
 
b
 
-glycerophosphate, 6 mM so-
dium pyrophosphate, 2 mM EDTA, 2 mM EGTA, 4 
 
m
 
g/ml leupeptin, 4
 
m
 
g/ml aprotinin, 2% NP-40, 20% glycerol, 2 mM DTT). 1 
 
m
 
l of antibody
was added to 200 
 
m
 
l supernatant and incubated on ice for 1 h. The formed
immune complexes were collected with 50 
 
m
 
l of a 1:1 slurry of protein A
beads in lysis buffer by incubation under agitation for 1 h at 4
 
8
 
C. The
beads were washed twice with lysis buffer and twice with kinase buffer (25
mM MOPS, pH 7.4, at room temperature, 25 mM 
 
b
 
-glycerophosphate, 20
mM magnesium chloride, 1 mM DTT, 30 mM KCl for myosin II assay).
PAKa activity was measured in an immunocomplex kinase assay after im-
munoprecipitation with the anti-FLAG antibody. The beads were incu-
bated with 75 
 
m
 
l kinase buffer containing 5 
 
m
 
Ci 
 
g
 
[
 
32
 
P]ATP, 5 
 
m
 
M cold
ATP, and 5 
 
m
 
g histone 2B or myosin II as a substrate. The reaction was
stopped by the addition of 25 
 
m
 
l 4
 
3
 
 sample buffer and boiling for 5 min.
The samples were separated by SDS-PAGE (12.5%), blotted onto a
PVDF membrane (Millipore Corp.), and exposed to film.
 
Chemotaxis Assay
 
Cells were pulsed with 30 nM cAMP at 6-min intervals for 5 h, and cells
were washed and resuspended in Na/KPO
 
4
 
 buffer containing 200 
 
m
 
M
CaCl
 
2
 
 and MgCl
 
2
 
. A small volume of cells was plated on glass-bottomed
microwell plates (MatTek, Inc.) and allowed to adhere to the surface for
 
z
 
20 min. A micropipette filled with 150 
 
m
 
M cAMP was positioned to
stimulate cells by using a micromanipulator (Eppendorf-Netheler-Hinz
GmbH), and the response and movement of cells was recorded by using a
time-lapse video recorder and NIH Image software (1 image every 6 s).
The movement of cells and changes of cell shape were analyzed with the
DIAS program (Wessels and Soll, 1998).
 
Isolation of Cytoskeletal Proteins
 
Cytoskeletal proteins were isolated as proteins insoluble in detergent NP-
40. Cells were harvested by centrifugation and resuspended at 10
 
8 
 
cells/ml.
cAMP (100 
 
m
 
M) was added to cells and 500 
 
m
 
l of cells were taken at each
time point and immediately added to 500 
 
m
 
l of 2
 
3
 
 lysis buffer as described
for the kinase assay. After vortexing a few times, the tubes were placed on
ice for 10 min, then allowed to warm to room temperature for 10 min. The
samples were spun for 4 min at 11,000 
 
g
 
 and the supernatant was dis-
carded. After washing with 1
 
3
 
 lysis buffer, the protein pellet was dis-
solved by boiling in 2
 
3
 
 SDS-PAGE sample buffer. Samples were run in
8% gel, and protein bands were stained with Coomassie blue. Protein
bands were scanned, and changes in myosin II content in cytoskeleton
were measured by using IPLAB software.
 
Two-Hybrid and Overlay Analysis
 
Rac1B, RacE, RasG, and human Cdc42 were amplified by PCR and
cloned into yeast two-hybrid fish vector pG4-5 as described previously
(Lee et al., 1997, 1999). The clones were sequenced to confirm the reading
frame and the absence of mutations. Point mutations corresponding to
Q61L in Ras were made with the Transformer Site Directed Mutagenesis
Kit from CLONTECH Laboratories, Inc. Constructs containing site-
directed mutants were sequenced to confirm the nucleotide substitutions
and the absence of other mutations. Rac1B was a generous gift from Su
Dharmawardhane (University of Texas, Austin, TX), RacE was from Ar-
turo De Lozanne (Duke University, Durham, NC), RasG was from Rob-
ert Insall (University of Birmingham, UK), and HsCdc42 was from
Michael Karin (University of California, San Diego, CA).
For overlay assays, Rac1B and HsCdc42 were cloned into GST fusion
constructs. The constructs were sequenced to confirm the reading frame
and the absence of errors in the cloning/amplification. GST fusion pro-
teins were produced in 
 
Escherichia coli 
 
and overlay assays done according
to the methods of Manser et al. (1994).
 
Results
 
Cloning of PAKa
 
We identified PAKa in a PCR screen for PAK/Ste20 fam-
ily kinases using degenerate primers based on conserved
sequences in the kinase domains of Ste20 and mammalian
PAK. Sequenced PCR products carrying part of a poten-
tial PAK family member were used to screen a cDNA li-
brary and several family members were identified, one be-
ing PAKa. One 
 
z
 
3.5-kb PAKa cDNA clone contained the
complete PAKa open reading frame (Fig. 1 A). The do-
main structure of PAKa is similar to that of mammalian
PAK1 (Fig. 1 B). PAKa has a predicted Cdc42/Rac, a
small G protein binding domain (CRIB), a COOH-termi-
nal kinase domain, and a long NH
 
2
 
-terminal putative regu-
latory domain containing a highly acidic region and a po-
tential SH3-interacting polyproline stretch. In addition,
the NH
 
2
 
-terminal domain contains an Akt/PKB and multi-
ple cAMP-dependent kinase (PKA) consensus phosphor-
ylation sites. Comparisons of the kinase and CRIB do-
mains of PAKa and other members of this family are
shown in Fig. 2, A and B, respectively. The PAKa kinase
domain has the highest sequence identity to the kinase do-
main of 
 
Dictyostelium
 
 MIHCK (59% identity) and human
PAK1, mouse PAK3, and 
 
Saccharomyces pombe
 
 PAK1
(
 
z
 
48% identity each).
Figure 1. Deduced sequence of PAKa. A, The cDNA clone,
PAKa 6-1, has an insert of 3670 nt and contains the entire PAKa
open reading frame. The boxed region depicts the conserved ki-
nase domain. The underlined region shows acidic domain. The
bolded and underlined sequence represents a polyproline stretch.
The shaded sequence indicates the CRIB domain. The GenBank/
EMBL/DDBJ accession number for PAKa is AF131221. B, Sche-
matic diagrams of PAKa and PAKa mutants. C, Developmental
RNA blot of PAKa expression. 6 mg of total RNA was loaded in
each lane and probed (Datta and Firtel, 1987). Time in develop-
ment is shown. 0 h, vegetative cells. 
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The PAKa CRIB domain shares strong homologies with
the CRIB domain of 
 
Dictyostelium
 
 MIHCK and PAKs
from other species (Fig. 2 B). To examine the specificity of
the PAKa CRIB domain for small G proteins, we used the
yeast two-hybrid system (Gyuris et al., 1993) to assay the
interactions of the PAKa CRIB domain with activated
forms of 
 
Dictyostelium
 
 Rac1B, human Cdc42 (a 
 
Dictyoste-
lium
 
 homologue has not yet been identified), 
 
Dictyoste-
lium
 
 RacE, and 
 
Dictyostelium
 
 RasG, the latter two of
 
which are required for cytokinesis in 
 
Dictyostelium
 
 (Vith-
alani et al., 1996; Tuxworth et al., 1997). As we show in
Fig. 2 C, the PAKa CRIB domain preferentially interacts
with DdRac1B and HsCdc42. We confirmed the interac-
tion of DdRac1B and HsCdc42 with the PAKa CRIB us-
ing an overlay assay (Manser et al., 1994). We observed
strong interaction of a GST-CRIB/PAK fusion protein
with DdRac1B
 
GTP
 
g
 
S
 
 and Cdc42
 
GTP
 
g
 
S 
 
(data not shown).
These results are consistent with, but do not prove, that
PAKa is a member of the PAK family of Rac/Cdc42-regu-
lated protein kinases.
Northern blot analysis indicates that PAKa encodes a
single developmentally regulated transcript (3.7 kb) that is
expressed in vegetative and early developing cells, and is
upregulated during aggregation and multicellular stages
(Fig. 1 C). No hybridization signal was detected when the
probe was used on a blot carrying RNA isolated from
 
paka
 
 null cells (data not shown).
 
paka Null Cells Have a Defect in Cytokinesis
and Development
 
PAKa
 
 was disrupted by homologous recombination (see
Materials and Methods). Random transformants were se-
lected and screened for disruption of PAKa by Southern
and RNA blot analysis. All clones that showed disruption
of 
 
PAKa
 
 did not exhibit an mRNA signal on RNA blots,
and had the same developmental and growth phenotype.
As depicted in Fig. 3 A, 
 
paka
 
 null cells exhibit a defect in
completing cytokinesis when grown in suspension. Under
these conditions, the increase in cell number indicates
 
paka
 
 null cells grow more slowly than wild-type cells be-
cause the cells become multinucleate, as revealed by an in-
crease in number of nuclei in a cell (Fig. 3). When grown
in suspension for five days, 
 
paka
 
 null cells are considerably
larger than wild-type cells, and DAPI (4
 
9
 
, 6-diamidino-
2-phenylindole) staining shows an average of eight nuclei
per cell (Fig. 3 B). However, when paka null cells are
grown on plastic, they grow predominantly as mono- and
dinucleate cells (data not shown), dividing by traction-
mediated cytofission, as previously described for myoII
null cells (De Lozanne and Spudich, 1987; Fukui et al.,
1990). Our data suggest that paka null cells might have dif-
ficulties in regulating cytoskeletal organization required
for cytokinesis, but karyokinesis is normal. The cytokine-
sis and developmental defects of paka null cells can be
complemented by overexpression of PAKa from the Actin
15 (Act15) promoter (data not shown).
To examine the effect of disrupting PAKa on multicellu-
lar development, we plated paka null and wild-type cells
on nonnutrient agar and followed development. Com-
pared with wild-type cells, development of paka null cells
is very delayed (Fig. 4). Tight aggregates do not form until
16–17 h, and some mounds arrest at this stage. For those
that proceed further, the first fingers are not formed until
z24 h. Mature fruiting bodies form at z36 h, containing
sori that are smaller than those of wild-type cells (data not
shown). To examine the role of PAKa further, we created
a series of PAKa mutant constructs: a kinase dead, puta-
tive dominant negative mutant of PAKa made by chang-
ing the Lys residue in the ATP binding site in the kinase
domain to Ala (PAKaK394A, designated PAKaDN); a puta-
Figure 2. A, Amino acid sequence comparison of the kinase do-
main of PAKa with PAKs from a variety of organisms. DdP, Dic-
tyostelium PAKa; DdM, Dictyostelium MIHCK; Hs, human
PAK1; mo, mouse PAK3; Sp, Saccharomyces  pombe PAK1.
GenBank/EMBL/DDBJ accession numbers: human PAK1,
Q13153; mouse mPAK-3, g1168176; Saccharomyces pombe
PAK1, P50527; Dictyostelium discoideum MIHCK, U67716. B,
Amino acid sequence comparison of the CRIB domain of PAKa
with PAKs from other organisms. C, Interaction of CRIB do-
main of PAKa with small G proteins in the yeast two-hybrid sys-
tem developed in the laboratory of Roger Brent (Gyuris et al.,
1993), which was used to examine the interactions between
PAKa and small G proteins as described previously (Lee et al.,
1997). The CRIB domain of PAKa was cloned into bait vector
pEG202. Constitutively active Rac1B, RacE, RasG, and human
Cdc42 were cloned into fish vector pG4-5. EGY48. Yeast was
transformed with PEG202, pG4-5, and a reporter construct. Sev-
eral colonies were picked and plated on Gal/CM Ura2His2Trp2
plates containing X-gal. The picture depicts color development
4 d after plating. DdRac1B and HsCdc42 show strong interaction
with the CRIB domain of PAK, as colonies are dark blue on
X-gal plates. In contrast, RacE and RasG have very weak inter-
actions, as colonies do not show any color development. RasG in-
teracts strongly with the Ras-interacting domains of RIP3 (Lee
et al., 1999) and PI3K1 and PI3K2 in the same yeast two-hybrid
system. Under these conditions, Rac1B and HsCdc42 do not in-
teract with the RIP3 Ras interacting domain. There are no
known proteins that interact with RacE.Chung and Firtel PAK Regulation of Chemotaxis 563
tive constitutively active PAKa (PAKaCA) containing only
the kinase domain (the NH2-terminal regulatory domain is
thought to function as a negative regulatory module and
its deletion in mammalian PAKs leads to a constitutively
active kinase; Cairns et al., 1992); a PAKa mutant contain-
ing the CRIB and kinase domains (PAKaG1K); and a
PAKa carrying the NH2-terminal myristoylation signal
from Src (myrPAKa), which has been demonstrated to con-
stitutively target mammalian and Dictyostelium proteins
uniformly to the plasma membrane (Buser et al., 1994;
Meili et al., 1999). The structures of these constructs are
shown in Fig. 1 B.
We overexpressed the mutant PAKs and wild-type
PAKa from the constitutive Act15 promoter. For these ex-
periments, the overexpression mutants were selected at
high G418 concentrations to yield clones expressing a high
level of the specific PAKa protein (see Materials and
Methods). Cells expressing PAKaDN have a phenotype
similar to, but more severe than, that of paka null cells
(Fig. 4). Aggregation is very delayed and most mounds ar-
rest and do not develop further. The more severe pheno-
type of PAKaDN-expressing cells compared with paka null
cells may be due to the inhibition of another PAK-like ki-
nase by PAKaDN. Cells overexpressing PAKaCA exhibit
severe aggregation defects and never form mounds.
We targeted PAKa to the plasma membrane by express-
ing myrPAKa. Indirect immunofluorescence indicates that
myrPAKa, also tagged at the COOH terminus with the
FLAG epitope, localizes uniformly to the plasma mem-
brane around cells (see Fig. 8, B, f). These cells exhibit
very delayed aggregation and development, suggesting
that proper subcellular localization of PAKa might be im-
portant for regulating the in vivo function of PAKa during
aggregation (Fig. 4). Cells overexpressing wild-type PAKa
or PAKaG1K exhibit a wild-type pattern of aggregation
and multicellular development, and form normal-looking
fruiting bodies (data not shown).
Aberrant F-actin Organization in paka Null Cells and 
Cells Expressing PAKa Mutants
To examine whether overexpression of PAKa mutants has
an impact on the actin cytoskeleton, we performed phal-
loidin staining of aggregation-competent cells. Wild-type
cells are usually polarized and show localized F-actin as-
sembly at lamellipodia of the leading edge and sometimes,
to a lesser degree, at the posterior cortical region of the re-
tracting cell body (Fig. 5). paka null cells also appear elon-
gated, but are not as polarized in the distribution of the ac-
tin cytoskeleton as wild-type cells. paka null cells have
multiple, randomly localized F-actin–rich pseudopodia-
like protrusions (Fig. 5, arrows). Cells overexpressing
wild-type PAKa (PAKaOE), although lacking a develop-
mental phenotype, exhibit changes in F-actin organization.
PAKaOE cells have multiple F-actin–enriched crowns
along the periphery of cells (Fig. 5). This pattern is very
similar to that of racgap1 null cells and cells overexpress-
ing constitutively active DdRac1B (DdRac1BQ61L; Chung,
C.Y., S. Lee, C. Briscoe, and R.A. Firtel, manuscript sub-
mitted for publication), suggesting that the activity of
PAKa might be regulated via Rac1B. Despite this aber-
rant F-actin organization, PAKaOE cells are elongated.
Cells expressing PAKaDN lack prominent actin-rich la-
mellipodia and actin staining is very diffuse and scattered
around the cell periphery (Fig. 5). Some of the cells show
microspikes (see lower panel for PAKaDN, Fig. 5), but
these microspikes do not appear to be enriched in F-actin.
In contrast, cells expressing PAKaCA accumulate assem-
bled F-actin in multiple membrane ruffles over the entire
cell. Some of these cells are multinucleate, although not to
Figure 3. Multinucleated paka null cells due to defective cytoki-
nesis. A, Defective cytokinesis in paka null cells. Phase-contrast
and epifluorescent micrographs of multinucleated paka null cells
grown in shaking culture for 5 d. Nuclei were visualized with
DAPI. B, Increase of the number of nuclei in paka null cells.
Wild-type KAx3 and paka null cells were transferred from plates
into axenic medium in shaken culture at 0 h and the number of
nuclei in a cell were counted at intervals thereafter. Cells were
counted using a hematocytometer. When paka null cells are
grown in suspension for 5 d, there are an average of eight nuclei
per cell.The Journal of Cell Biology, Volume 147, 1999 564
the extent of paka null cells, suggesting that a putative
nonregulated form of PAKa, as well as a lack of PAKa,
can result in cytoskeletal defects that prevent proper cy-
tokinesis. Moreover, although these cells elongate, they
fail to show a polarization of the actin cytoskeleton, con-
sistent with their inability to aggregate properly. These re-
sults suggest that PAKa can mediate rearrangements in
the actin cytoskeleton.
Cells expressing PAKaG1K do not exhibit a prominent
change in F-actin distribution (data not shown) compared
with wild-type cells and in contrast to cells expressing
PAKaCA, suggesting that the CRIB domain might nega-
tively regulate kinase function, consistent with work on
human PAK1 (Sells et al., 1997). As wild-type PAKa has
the CRIB domain, it is possible that the upstream, NH2-
terminal sequences deleted in PAKaG1K are involved in
regulating the function of the CRIB domain in controlling
PAKa activation. Cells expressing myrPAKa exhibit do-
mains of F-actin along the entire membrane cortex, consis-
tent with a uniform distribution of myrPAKa along the cor-
tex of the cells (see Fig. 8 f). These cells fail to elongate or
polarize (Fig. 5). We expect that the upregulated assembly
of F-actin results from the activity of the membrane-local-
ized PAKa.
Abnormal Chemotactic Movement of paka Null Cells 
and Cells Expressing PAKa Mutants
To examine whether the changes in the cytoskeletal orga-
nization described above alter chemoattractant-induced
cell migration, we compared the chemotactic movement of
paka null cells to that of wild-type cells by examining their
movement toward the chemoattractant using the DIAS
image analysis software (Wessels and Soll, 1998). Cells
competent to chemotax toward cAMP (aggregation-com-
petent cells) were obtained by pulsing cells in suspension
for 5 h with 30 nM cAMP, conditions that mimic the
cAMP signaling during the phase leading up to aggrega-
tion in vivo (Devreotes et al., 1987; Mann and Firtel, 1987;
Saxe et al., 1991; Insall et al., 1994). This protocol maxi-
mally induces the expression of aggregation stage genes
required for aggregation, including the cAMP receptor,
cAR1, and the coupled G protein a subunit, Ga2. Wild-
type cells are usually well-polarized and move quickly and
Figure 4. Development of paka null cells and cells expressing PAKa mutants. Cells grown in axenic medium were washed and plated on
nonnutrient agar plates. Photographs were taken at various developmental stages thereafter. Development of paka null cells is delayed
in aggregation and late development. Cells expressing dominant negative PAKa (PAKaDN) and myristoylated PAKa (myrPAKa) exhibit
delayed aggregation similar to that of paka null cells. The phenotype of myrPAKa is more severe than either paka null or PAKaDN cells.
Cells expressing constitutively active PAKa (PAKaCA) have a severe defect in aggregation and never form mounds.Chung and Firtel PAK Regulation of Chemotaxis 565
linearly toward the cAMP source. As we show in Fig. 6 A,
wild-type cells produce pseudopodia almost exclusively at
the edge in the direction of the micropipette, and produce
very few random lateral or rear pseudopodia (an average
of 1.5 lateral pseudopodia per 10 min). Wild-type cells
make few changes in the direction of movement, as shown
in Fig. 6 A. In sharp contrast, paka null cells produce more
random pseudopodia (an average of 6 lateral pseudopodia
per 10 min, some of which are marked with open arrow-
heads in Fig. 6 B) in various directions. In addition, paka
null cells exhibit random changes in the direction of move-
ment, which might result from the protrusion of lateral
pseudopodia, leading to an inefficient chemotaxis toward
the cAMP source. The movement of the four paka null
cells shown in Fig. 6 B illustrates these phenotypes. Cells
protrude multiple pseudopodia and, in cell c, two pseu-
dopodia in the same cell become dominant (rather than
one), resulting in the formation of two independent lead-
ing edges and the independent movement of the two
halves that remain connected.
In addition, paka null cells do not retract their rear cell
body as efficiently as wild-type cells. The posterior of wild-
type cells contracts and lifts from the substratum after the
leading-edge pseudopod has been extended (Jay et al.,
1995);  paka null cells appear defective in this process (Fig.
6 B: asterisk in a and c marks the rear cell body of the paka
null cells, which remain tightly associated with the substra-
tum). As illustrated by Fig. 6 B, cells a and c, the anterior
of the paka null cell continues to extend its cell body to-
ward the cAMP source until the cell reaches a certain
length and then the posterior retracts very rapidly. Proba-
bly due to the combination of random changes of the di-
rection of movement and the difficulty in retracting the
rear cell body, the speed of movement of paka null cells
(4.95 mm/min) is about half that of wild-type cells (8.63
mm/min).
PAKaDN cells produce more random pseudopodia than
wild-type cells and have an increased frequency of turning,
similar to paka null cells (Fig. 6 C). PAKaDN cells exhibit
difficulty in retracting the rear cell body as depicted in Fig.
6, C, c. As the leading edge of a cell moves forward, the
rear cell body elongates, due to the lack of retraction, and
then retracts very rapidly. PAKaCA cells, as expected from
the upregulated F-actin assembly over the entire cell, are
Figure 5. Organization of the
actin cytoskeleton in paka
null cells and cells expressing
PAKa mutants. Cells were
plated on glass coverslips and
starved for 5–6 h before fixa-
tion with 3.7% formalde-
hyde in 12 mM Na/KPO4 (pH
6.1) for 5 min. After washing,
cells were treated with block-
ing solution (PBS, 0.1% Tri-
ton X-100, 0.1% BSA) and 10
ng of FITC or rhodamine-
labeled phalloidin was added
to each glass coverslip. Note
that wild-type cells have
F-actin–rich lamellipodia at
the leading edge that are ab-
sent in paka null cells and
cells expressing PAKaDN.
Cells expressing PAKaCA ac-
cumulate F-actin all over the
cells. Cells overexpressing
wild-type PAKa are elon-
gated and have discrete actin-
enriched domains along the
periphery of the cell. Cells
expressing myrPAKa exhibit
domains of assembled F-actin
along the entire membrane
cortex.  paka null cells exhibit
multiple pseudopod-like, ac-
tin-enriched blebs. Some of
these are marked with an ar-
row. Bar, 5 mm.The Journal of Cell Biology, Volume 147, 1999 566
Figure 6. Abnormal chemo-
tactic movement of paka null
cells and cells expressing
PAKa mutants. Wild-type
and paka null cells were
washed and pulsed for 4.5 h
with 30 nM cAMP every 6
min (see Materials and
Methods). Cells were plated
on a plastic petri dish con-
taining a hole, over which a
glass microscope slide was
glued. The tip of the micropi-
pette containing 100 mM
cAMP was placed near the
cell as described in detail
previously (Meili et al.,
1999). The movement of cells
toward the tip was recorded
with NIH Image software at
6-s intervals and the move-
ment of cells and shape
changes were analyzed with
the DIAS program, a newly
developed image analysis
system. A, Wild-type cells
are well-polarized and move
toward the cAMP gradient
without making lateral
pseudopodia. Left panel
shows superimposed images
representing cell shape at
1-min intervals. Right panel
shows the change of direc-
tion in which the leading
edge of the migrating cell
headed. Solid arrows point
out the direction of the mi-
cropipette filled with 100 mM
cAMP. Note that wild-type
cells do not make lateral
pseudopodia and do not
change their direction of
movement very often. Bar,
20  mm. The number of newly
formed pseudopodia was
counted in each image for
the 10-min time period of the
experiment. B, paka null
cells protrude many random
lateral pseudopodia (average
z6 lateral pseudopodia in 10
min, some of which are
marked with open arrows)
and the posterior cell bodies
(marked with asterisks, a and
c) of null cells are elongated,
due to the difficulty in re-
tracting. Due to frequent
changes of the direction
of movement, the speed of
chemotactic movement of
paka null cells is slower than
that of wild-type cells. C,
Cells expressing PAKaDN
make many random lateral
pseudopodia and show elon-
gated posterior cell bodies due to the difficulty of retraction (c). D, Cells expressing PAKaCA are very flattened and stationary. They
are not polarized and move very slowly in random directions.Chung and Firtel PAK Regulation of Chemotaxis 567
flattened and appear adherent and stationary. The cell–
substratum contact area of these cells is significantly larger
than that of wild-type cells (Fig. 6 D). Upon stimulation by
cAMP, PAKaCA cells do not polarize and produce few
dominant pseudopodia. These cells are not capable of
changing their shape; hence, their migration is very slow.
Our results suggest that PAKa plays an important role in
the regulation of cytoskeletal organization, which is pre-
sumably required for maintaining cellular polarity and
preventing the formation of random, lateral pseudopodia.
The inhibition of the formation of random pseudopodia
might prevent cells from making random changes of direc-
tion when moving up a chemoattractant gradient.
Subcellular Localization of PAKa
To examine where PAKa is localized in polarized, aggre-
gation-competent cells, PAKa was tagged with FLAG at
the COOH terminus or HA at the NH2 terminus, and ex-
pressed in wild-type cells. The transformants carrying a
construct of tagged PAKa were selected and maintained at
a low concentration of G418 to select strains that ex-
pressed PAKa at a low level. Strains were selected for
those that did not exhibit the altered actin cytoskeletal de-
fects shown in the high overexpression strains used in Figs.
4 and 5. The localization of tagged PAKa was determined
in aggregation-competent cells by indirect immunofluores-
cence. FLAG-tagged PAKa mostly localizes to the poste-
rior cortical region of the cell body (Fig. 7 B) and is not
found in the leading edge where F-actin is concentrated
(Fig. 7 A). The staining pattern of FLAG-PAKa in the
posterior cortex overlaps with the phalloidin staining of
F-actin in that region. Similarly, HA-tagged PAKa local-
izes to the posterior cortex (Fig. 7, D and E). Knowing that
paka null cells have a cytokinesis defect, we examined the
localization of HA-tagged PAKa in wild-type cells under-
going cytokinesis. As depicted in Fig. 7, F and G, HA-
PAKa localizes to the cortex of the cleavage furrows of di-
viding cells. These results are consistent with involvement
of PAKa in cytokinesis.
The subcellular localization of PAKa during chemotaxis
and cytokinesis is very similar to that of myosin II. This
Figure 7. Localization of
PAKa in the cell. The distribu-
tion of PAKa was examined in
cells expressing FLAG- (at the
COOH terminus) or HA- (at
the NH2 terminus) tagged
PAKa by indirect immunofluo-
rescence staining as described
in the Materials and Methods.
A, Distribution of F-actin
stained with FITC-phalloidin.
F-actin is mainly concentrated
at the leading edge of a migrat-
ing cell, but is found in the pos-
terior cell body. B, Localiza-
tion of FLAG-tagged PAKa in
a cell at the aggregation stage.
PAKa localizes in the posterior
cell body. C, Merge of A and
B. Note that F-actin staining
and PAKa staining are over-
lapped in the posterior cell
body. D and E, Distribution of
HA-tagged PAKa in cells at
the aggregation stage. Note
that PAKa is concentrated at
the posterior cortex. F and G,
Localization of HA–PAKa in
the cleavage furrow. Bar, 5 mM.The Journal of Cell Biology, Volume 147, 1999 568
raises the possibility that PAKa might regulate myosin II
and, in turn, control the cytoskeletal organization in the
posterior cell body. To test this possibility, we examined
the distribution of a myosin II–green fluorescent protein
(GFP) fusion protein (Moores et al., 1996) in wild-type
cells and paka null aggregation stage cells. Myosin II–GFP
mainly localizes at the cortex of the rear cell body in wild-
type cells (Fig. 8 A) as has been described previously
(Yumura et al., 1984; Yumura and Fukui, 1985; Moores
et al., 1996). However, in paka null cells, we observe a
much more diffuse staining pattern of myosin II–GFP
throughout the cells and no posterior cortical cap. We ex-
amined the localization of myosin II by indirect immuno-
fluorescence staining using the antimyosin II antibody
(Egelhoff et al., 1991). Myosin II is concentrated in the
posterior cell body in aggregation-competent wild-type
cells (Fig. 8 B) as shown by the myosin II–GFP fusion,
whereas the staining of myosin II in paka null cells does
not exhibit a strong subcellular localization. In contrast,
we found strong myosin II staining along the membrane
cortex of cells expressing myrPAKa, suggesting that an-
choring PAKa to the plasma membrane promotes assem-
bly of myosin II filaments at the membrane cortex (Fig. 8
B). This increased myosin II assembly at the membrane
cortex is not found in cells expressing myrPAKaDN (Fig. 8,
B, d), reflecting that myosin II assembly at the membrane
cortex is due to the PAKa activity. However, cells express-
ing myrPAKaDN do not have a posterior that is enriched
in myosin II. We expect this is because myrPAKaDN func-
tions (like non–myr-tagged PAKaDN) as a dominant nega-
tive protein and inhibits intrinsic PAKa activity. Like
myrPAKa,  myrPAKaDN predominantly localizes to the
membrane cortex as determined by immunostaining (Fig.
8, B, f; data not shown for myrPAKaDN).
Cells expressing PAKaCA have regions highly enriched
in myosin II throughout the cell. These highly enriched
myosin II-containing regions probably contain highly as-
sembled myosin II. This result strongly suggests that
PAKa might be involved in the regulation of myosin II as-
sembly into the cytoskeleton. To test this idea, we deter-
mined the amount of myosin II in cytoskeleton fraction in
wild-type cells, paka null cells, and cells expressing PAKCA
in both vegetative growth and aggregation stages. In vege-
tatively growing cells, the level of myosin II assembled
into the cytoskeleton in both wild-type and paka null cells
is low, compared with cells at the aggregation stage (Fig. 9
A). However, cells expressing PAKCA display a higher
level (approximately four times higher than wild-type
cells) of myosin II assembly in the cytoskeleton. This re-
sult is consistent with PAKa activity being involved in reg-
ulating myosin II assembly.
The level of myosin II in the cytoskeleton in aggrega-
tion-competent, wild-type cells is significantly higher
(seven to eight times higher) than that in growth-stage,
Figure 8. A, Localization of
GFP–myosin II in aggrega-
tion stage wild-type or paka
null cells. Myosin II is local-
ized at the posterior cortex of
wild-type cells, but not in
paka null cells. GFP–myosin
II is very diffuse throughout
the null cells. B, The localiza-
tion of myosin II was exam-
ined by indirect immuno-
fluorescence staining with
antimyosin II heavy chain an-
tibody (a–e). Similar to GFP–
myosin II, the staining of my-
osin II is concentrated at the
posterior cortex. In paka null
cells, the staining of myosin II
is very diffuse over the cell. In
cells expressing myrPAKa,
myosin II staining is localized
at the membrane cortex
throughout the cells. How-
ever, this localized myosin II
assembly at membrane cor-
tex is not observed in cells ex-
pressing myrPAKaDN. Cells ex-
pressing PAKCA show regions
of very strong myosin II stain-
ing, presumably due to the
high level of assembled myo-
sin II. myrPAKa appears to be
targeted to the membrane as
determined by localization
of  myrPAKa–FLAG by immunofluorescence staining (f). The intracellular staining is nuclear, which was sometimes observed in Dictyo-
stelium cells using the FLAG antibody. Bar, 5 mm.Chung and Firtel PAK Regulation of Chemotaxis 569
vegetative cells (Fig. 9 A). This difference is probably due
to myosin II assembly in the rear cell body upon cell polar-
ization in aggregation-competent cells. In paka null cells,
the level of assembled myosin II is z65% of that of wild-
type cells, suggesting that PAKa is required to control the
level of myosin II assembly. Interestingly, there is no strik-
ing difference of myosin II level between wild-type cells
and cells expressing PAKCA at the aggregation stage
(probably because the assembly of myosin II is already ac-
tivated in aggregation-competent cells).
We examined whether PAKa function is important in
controlling changes in myosin II assembly into the cyto-
skeleton upon cAMP stimulation (Liu and Newell, 1988).
As shown in Fig. 9 B, in response to cAMP stimulation,
the level of myosin II heavy chain in the cytoskeletal frac-
tion in wild-type cells rises to a peak at 20–30 s and returns
to the basal level by 60–80 s, consistent with previous ob-
servations (Liu and Newell, 1988). However, this peak of
myosin II assembly upon cAMP stimulation into the cy-
toskeleton is absent in paka null cells. These results sug-
gest that PAKa might be involved in regulating myosin II
assembly via either direct phosphorylation of myosin II or
regulation of kinases controlling myosin II assembly.
Regulation of PAKa in Kinase Activity and its 
Localization upon Chemoattractant Stimulation
To determine whether Dictyostelium PAKa activity is
stimulated in response to the chemoattractant, aggrega-
tion stage cells expressing FLAG-tagged PAKa were stim-
ulated by cAMP, lysed at various times after stimulation,
and PAKa–FLAG was immunoprecipitated from the de-
tergent-soluble fraction (see Materials and Methods). Fig.
10 A shows that the kinase activity of immunoprecipitated
PAKa towards a nonspecific substrate, H2B, rapidly in-
creases three- to fourfold in response to cAMP. Maximal
H2B phosphorylation is obtained within 30 s, after which
the activity decreases slowly with kinetics similar to those
of the adaptation of cAMP receptor-stimulated ERK2 ki-
nase activity (Maeda and Firtel, 1997). The kinetics of
PAKa activation are very similar to those of PAK activa-
tion in human neutrophil stimulated by fMet-Leu-Phe
(Knaus et al., 1995).
In a process of verifying that there is an equal amount of
PAKa–FLAG in each immunoprecipitate, we observed
that the amount of PAKa–FLAG in the detergent-soluble
fraction is rapidly decreased in response to cAMP. This
decrease of PAKa–FLAG in the detergent-soluble frac-
tion is due to the incorporation of PAKa–FLAG into a de-
tergent-insoluble cytoskeleton fraction (Fig. 10 C). The ki-
netics of PAKa relocalization into the cytoskeleton are
very similar to the kinetics of myosin II assembly into the
cytoskeleton upon cAMP stimulation. This result suggests
that PAKa is involved in the regulation of myosin II as-
sembly. When PAKa kinase activity is normalized for the
amount of PAKa protein, activity increases approximately
ninefold.
We tested whether PAKa might directly regulate myo-
sin II through its phosphorylation in the COOH-terminal
tail fragment (Egelhoff et al., 1991; Yumura and Kitanishi-
Yumura, 1992). As shown in Fig. 10 A, we do not observe
myosin II phosphorylation by PAKa, suggesting that
Figure 9. A, Level of myosin II content in cytoskeleton fractions
of wild-type cells, paka null cells, and cells expressing PAKaCA.
Cells (2 3 107) grown in axenic medium in shaken culture were
collected by centrifugation and lysed with lysis buffer (see Mate-
rials and Methods). For aggregation-competent cells, the same
number of cells was plated on a 100-mm petri dish, washed twice
with phosphate buffer, and starved for 5 h. After 5 h, cells were
lysed by adding lysis buffer and lysates were collected by using a
rubber policeman. Lysates (containing 500 mg of protein) were
spun at 11,000 g for 4 min to collect the pellet containing the cy-
toskeletal fraction, which was washed once with lysis buffer. The
pellet was dissolved in 23 SDS-PAGE sample buffer and boiled
for 5 min. Samples were run on 8% SDS gels and proteins were
stained with Coomassie blue. Gel bands were scanned and
changes in myosin II content were quantified with IPLAB soft-
ware. In the vegetative, growing stage in wild-type and paka null
cells, little of the myosin II is assembled into the cytoskeleton
fraction, but the cytoskeleton from cells expressing PAKaCA has
a much higher myosin II content, resulting from higher PAKa ac-
tivity. In the aggregation stage, the myosin II level is elevated in
all three cell types, but paka null cells exhibit a lower level of my-
osin II content than wild-type cells. B, Changes of myosin II con-
tent in the cytoskeleton upon cAMP stimulation. Cells were
pulsed (see Materials and Methods), washed with phosphate
buffer, and incubated in 1 mM caffeine for 10 min. After washing
the cells, 100 mM cAMP was added and an equal number of cells
was collected at specific time points. Cell lysis was immediate.
Determination of the myosin II content in the cytoskeleton frac-
tion was done as described above and graphed in the lower part
of the figure. The data are from four separate experiments. Myo-
sin II content peaks at 30 s after cAMP stimulation in wild-type
KAx3 cells, but this peak is missing in paka null cells.The Journal of Cell Biology, Volume 147, 1999 570
PAKa indirectly regulates the assembly of myosin II,
probably via the regulation of MHCKs. As expected,
PAKCA immunoprecipitated from aggregation-competent
cells has three to four times higher basal activity against
H2B (Fig. 10 B), but the activity is not regulated in re-
sponse to cAMP stimulation, probably because the activity
is already maximal.
Translocation of PAKa upon Change of Cell Polarity
To access the localization of PAKa in live, migrating cells,
we fused the NH2-terminal regulatory domain of PAKa
(excluding the CRIB and kinase domains) to GFP. Cells
expressing N-PAKa–GFP chemotax normally (data not
shown). As we demonstrate in Fig. 11 A, N-PAKa–GFP
fusion protein localizes to the cortex at the cell’s posterior,
as we observed with FLAG- or HA-tagged PAKa, sug-
gesting the NH2-terminal domain used in this fusion is suf-
ficient for proper subcellular localization of PAKa. As
cells migrate, the N-PAKa–GFP fusion protein remains at
the rear cortical region (Fig. 11 A), suggesting that PAKa
activity is localized in the posterior and thus, may be im-
portant to maintain the polarity of cells during chemotaxis
and retract the posterior cell body. To determine whether
the localization of PAKa can be altered by disrupting cell
polarity, we examined the distribution of N-PAKa–GFP
by overlaying the cells with a receptor-saturating cAMP
solution (Fig. 11 B). As cells lose their polarity and round
up, N-PAKa–GFP remains associated with the cortex, but
diffuses away from its previous location to be distributed
along the membrane cortex over the entire cell. Fig. 11 C
shows the quantification of the stimulus-induced relocal-
ization of N-PAK–GFP at the plasma membrane. The dif-
ferences in fluorescence intensities before and after the
addition of cAMP over the cell were measured along a
thin line through the central portion of cells. In the polar-
ized cell (frame 1), the fluorescence intensity in the rear
cell body is tenfold higher than the intensity in the leading
edge. However, the fluorescence intensity in the rear cell
body is remarkably reduced by 50 s after cAMP stimula-
tion. The intensity in the leading edge is increased z2.5
times. The kinetics of the translocation of N-PAK–GFP
from the rear cell body to leading edge are presented in
Fig. 11 D as a measure of the fluorescence intensity along
the thin line through the anterior part of the cell. The
translocation of N-PAK–GFP reached maximum z30–40 s
after stimulation, which is similar to the kinetics of PAK
kinase activity upon the cAMP stimulation.
To examine whether the localization of holo-PAKa
shows similar changes upon cAMP stimulation, cells ex-
pressing PAKa–FLAG were pulsed and plated on cover-
slips. Cells were bathed with 100 mM cAMP and fixed at 0,
25, and 50 s after cAMP stimulation and the localization of
PAKa–FLAG was determined by indirect immunofluores-
cence staining. PAKa was localized in the rear cell body of
polarized, unstimulated cells (Fig. 12) and relocalized
along the membrane cortex 25 s after cAMP stimulation,
which is very similar to the relocalization of N-PAK–GFP.
In contrast to the distribution of N-PAK–GFP, PAKa
staining in cells fixed at 50 s was absent in the cortex where
new pseudopodia were formed, suggesting PAKa might be
excluded in newly formed pseudopodia. The difference in
the behavior between PAKa and N-PAK–GFP might re-
sult from the lack of a CRIB domain in N-PAK–GFP.
Discussion
PAKa Exhibits a Dynamic Subcellular Localization
We have identified a gene encoding a serine/threonine ki-
Figure 10. A, Activation of PAKa upon stimulation of cells with
cAMP. PAKa activity of immunoprecipitates towards histone 2B
and myosin II as substrates is shown. Aggregation stage cells ex-
pressing FLAG-tagged PAKa (see Materials and Methods) were
activated by cAMP. Aliquots were taken at various time points
after stimulation. Cells were lysed, PAKa was precipitated using
an anti-FLAG mAb, and kinase activity was measured as de-
scribed in Materials and Methods. Phosphorylation of histone 2B
(H2B), but not myosin II, is stimulated by cAMP. B, Activity of
PAKaCA compared with PAKa. Cells expressing FLAG-tagged
PAKa and PAKaCA were pulsed and PAKa and PAKaCA were
immunoprecipitated with anti-FLAG antibody. Kinase activity
was measured as described above. The same amount of PAKaCA
(determined by Western analysis with anti-FLAG antibody)
showed a much higher basal activity than PAKa. C, Incorpora-
tion of PAKa–FLAG into the cytoskeleton upon the stimulation
of cAMP. Cells were prepared as described in the kinase assay
and cell lysate was spun at 11,000 g for 5 min to collect the deter-
gent-insoluble cytoskeleton fraction. The amount of PAKa–
FLAG in the detergent-soluble cytosol and insoluble cytoskel-
eton fraction was determined by immunoblotting with the
anti-FLAG antibody. The level of PAKa–FLAG in the deter-
gent-soluble fraction was rapidly decreased upon the cAMP stim-
ulation and the level of PAKa–FLAG in the detergent-insoluble
cytoskeleton fraction was reciprocally increased. This relocaliza-
tion of PAKa–FLAG was reversible and the level of PAKa–
FLAG in the detergent-soluble fraction returned to the level of
unstimulated cells after 5 min. The kinetics of the incorporation
of PAK–FLAG are similar to those of PAKa activation by
cAMP. D, Quantification of PAKa activity. The PAKa activity
normalized by the amount of PAKa in the detergent-soluble frac-
tion was plotted. The data are from four separate experiments.Chung and Firtel PAK Regulation of Chemotaxis 571
nase, PAKa, that is a putative member of the PAK family
of protein kinases. We find that PAKa has a dynamic sub-
cellular localization. PAKa localizes to the cleavage fur-
row of cells undergoing cytokinesis and the posterior cor-
tex of polarized cells and colocalizes in the same region of
the cell with myosin II. Using a GFP fusion, we demon-
strate that the NH2-terminal region lacking the CRIB do-
main is sufficient for the proper subcellular localization of
PAKa in live, chemotaxing cells. If cells are overlaid with a
receptor-saturating concentration of cAMP, the N-PAKa–
GFP fusion proteins remain associated with the cell cor-
tex, but delocalize along the cortex of the cell as it loses its
polarized shape. Our data suggest that the NH2-terminal
domain associates with a dynamically localized component
of the cell cortex that is found in the posterior of polarized
cells. Moreover, we suggest that the establishment of po-
larity in the cortical region responsible for this localization
and the subsequent rearrangements of the cortical region
are controlled through the chemoattractant receptors. We
suggest that the localization of PAKa to a specific subdo-
main of the cell is a mechanism for restricting its activity to
a specific site in the cell. This might be particularly impor-
Figure 11. Localization of
N-PAKa–GFP protein in a
migrating Dictyostelium cell.
A, N-PAKa–GFP fusion pro-
tein was expressed in a wild-
type cell and the localization
of fusion protein was exam-
ined in a live, migrating cell.
Cells expressing GFP fusion
protein were pulsed with 30
nM cAMP for 5 h and plated
on a coverslip. The fusion
protein stays at the posterior
cortex while cell is moving. A
single cell was viewed at 20-s
intervals. A low level of visi-
ble light was used to view the
cell body in combination with
fluorescent GFP fusion pro-
tein. B, Localization of fusion
protein in a cell was exam-
ined when the cell lost polar-
ity by overlaying 150 mM
cAMP solution on the cell.
GFP fusion protein is origi-
nally localized at the poste-
rior cortex and diffuses along
the membrane cortex as the
cell loses polarity and starts
rounding up. A single cell
was viewed at 12-s intervals.
A solid white arrow points to
the leading edge. C, Quan-
tification of the stimulus-
induced relocalization of
N-PAKa–GFP at the plasma
membrane. The difference in
fluorescence intensities be-
fore and after the addition of
cAMP over the cell was mea-
sured along a thin line
through the central portion
of cells (Fig. 9 B, frames 1
and 8). D, Kinetic analysis
of the relocalization of
N-PAKa–GFP, along with
plasma membrane. The ki-
netics of the translocation of
N-PAKa–GFP from the rear
cell body to the membrane
cortex over the entire cell are
presented as a measure of the fluorescence intensity along the thin line through the anterior part of the cell. The translocation of
N-PAKa–GFP reached maximum z30–40 s after stimulation. The data shown are representative of multiple experiments.The Journal of Cell Biology, Volume 147, 1999 572
tant if its substrate is more uniformly distributed. Expres-
sion of PAKaCA, which is randomly localized in the cells,
or myrPAKa, which is uniformly membrane-localized, up-
regulates the actin and myosin cytoskeletons and the cells’
lack of cell polarity. These results are in agreement with
our view that PAKa’s tethering to the posterior of the cell
is an important aspect of regulating PAKa function and
may be important in maintaining the polarity of chemotax-
ing cells.
PAKa is a Regulator of the Myosin Component of the 
Cytoskeleton: Regulation of Cytokinesis
paka null cells exhibit two major phenotypes associated
with an inability to properly regulate the cytoskeleton: the
cells fail to complete cytokinesis when grown in suspen-
sion and the cells exhibit defects in chemotaxis. Our re-
sults provide the first identification of an essential role of a
putative PAK in cytokinesis. Dictyostelium cells and mam-
malian cells undergo cytokinesis via the formation and
constriction of a myosin II-rich contractile ring in the
cleavage furrow. myoII null cells do not divide in suspen-
sion due to the inability to perform cytokinesis, but un-
dergo cytokinesis on an adhesive surface by traction-medi-
ated cytofission in which dividing daughter cells are pulled
apart (Yumura et al., 1984; Yumura and Fukui, 1985; De
Lozanne and Spudich, 1987; Knecht and Loomis, 1988;
Manstein et al., 1989; Fukui et al., 1990; Moores et al.,
1996). Several small G proteins and GAPs are required for
proper cytokinesis in Dictyostelium. These genes include:
RasG (Tuxworth et al., 1997); two IQGAP-related genes,
Ddrasgap1 and GapA (Adachi et al., 1997; Lee et al.,
1997); and a novel Rac protein, RacE (Larochelle et al.,
1997). RasG might function via the activation of the PI3
kinase because deletions in two PI3 kinase genes (PI3K1
and PI3K2) lose the ability to grow in suspension (Zhou
et al., 1995) and RasG interacts with the Ras binding do-
main of PI3K1 and PI3K2 (Reddy, T.B.K., and R.A. Fir-
tel, unpublished observations). One of the IQGAP-related
proteins, Ddrasgap1, interacts with activated DdRac1B
and is thus a potential effector of Rac1B (Faix et al., 1998;
Lee, S., and R.A. Firtel, unpublished observations), which
interacts with PAKa. It is not known if Rac1B interacts
with Ddrasgap1 in vivo and regulates its role in cytokine-
sis. racE null cells fail to divide in suspension and become
multinucleated (Larochelle et al., 1997). RacE could be an
upstream regulator of PAKa. However, we only observe a
strong interaction with activated Rac1B in yeast two-
hybrid system and no interactions with activated RacE.
PAKa Functions during Chemotaxis as a Potential 
Regulator of the Myosin II Component of
the Cytoskeleton
paka null cells exhibit defects in chemotaxis and morpho-
genesis during multicellular development. The chemotaxis
phenotype is exemplified by inability of paka null cells or
wild-type cells expressing PAKaDN to maintain polarity,
regulate the formation of pseudopodia, and control the
contraction of the rear cell body during cell migration. In
chemotaxing cells, myosin II aligns along the posterior of
the cell, forming a C-shaped cap (Yumura et al., 1984;
Clow and McNally, 1999). This myosin cap contracts, caus-
ing the posterior of the cell to lift and allowing it to retract
towards the leading edge (Jay et al., 1995). In myoII and
paka null cells, the retraction of the posterior of the cell
during chemotaxis is defective (Jay et al., 1995; Clow
and McNally, 1999; this manuscript). We find that this
C-shaped cap of myosin II in wild-type cells is much less
visible or absent in paka null cells. Moreover, we found
that paka null cells are defective in the assembly of myosin
II into the cytoskeleton upon cAMP stimulation, suggest-
ing that PAKa is involved in the regulation of myosin II
assembly. In addition, cells expressing PAKaCA have a
much higher level of myosin II assembly in the cytoskele-
ton in vegetatively growing cells. These data are consistent
with PAKa playing an important role in the regulation of
myosin II assembly into the cytoskeleton.
Consistent with this, PAKa, as previously demonstrated
for myosin II (Varnum-Finney et al., 1987), is important
for suppressing lateral pseudopod formation. Both myoII
and paka null cells form more lateral pseudopodia than do
wild-type cells (Wessels et al., 1988; Wessels and Soll,
1990; this manuscript). The inability to inhibit lateral
pseudopod formation in myoII null cells may be associ-
ated with a reduction in cortical tension of these cells (Pas-
ternak et al., 1989). The higher frequency of protrusion of
lateral pseudopodia in paka null cells probably results
from the reduction in cortical tension due to the lack of
myosin II filament assembly at the posterior cortex. These
cytoskeletal defects might also be a major cause of the
morphological defects during multicellular development
of paka null cells and myoII null cells (Springer et al.,
1994; Chen et al., 1998).
Possible Model for PAKa Function in Controlling 
Myosin II Assembly
We demonstrate that PAKa kinase activity against H2B is
stimulated in response to cAMP; however, our data indi-
cate that myosin II is not phosphorylated by PAKa. This
observation is consistent with a requirement of PAKa for
the maintenance, but not the disassembly, of myosin II fi-
Figure 12. Redistribution of PAKa upon cAMP stimulation.
Cells expressing PAKa–FLAG were pulsed with 30 nM cAMP
for 5 h and plated on a coverslip. Cells were bathed with 100 mM
cAMP and fixed at 0, 25, and 50 s after stimulation. The localiza-
tion of PAKa–FLAG was examined by indirect immunofluores-
cence staining with anti-FLAG antibody. Arrows indicate newly
formed pseudopodia. Bar, 5 mm.Chung and Firtel PAK Regulation of Chemotaxis 573
bers. The regulation of myosin II filament assembly occurs
through receptor-mediated phosphorylation of myosin II
heavy chain tail and myosin II light chain (Berlot et al.,
1985; Gerisch et al., 1993). Phosphorylations at threonine
residues in the myosin II tail by two kinases, MHCKA and
MHC-PKC, lead to the disassembly of myosin filaments
(Berlot et al., 1985; Côté and McCrea, 1987; Vaillancourt
et al., 1988; Nachmias et al., 1989; Ravid and Spudich,
1989; Egelhoff et al., 1991). MHCKA is expressed during
growth and development (Futey et al., 1995). The mhckA
null cells are viable, but display partial defects in myosin
localization (Kolman et al., 1996). Cells overexpressing
MHCKA display reduced myosin II assembly in the cy-
toskeleton and become large and multinucleated in sus-
pension, which is very similar to phenotypes of myoII null
and paka null cells. In this context, PAKa is likely to regu-
late myosin II assembly via inhibition of MHCKA. MHC-
PKC is particularly interesting, since it translocates from
the cytosol to the plasma membrane/cortex and is acti-
vated upon cAMP stimulation, leading to the disassembly
of myosin II fibers (Dembinsky et al., 1996). Disruption of
the gene encoding MHC-PKC leads to an upregulation of
the myosin II cytoskeleton and chemotaxis defects (Abu-
Elneel et al., 1996). Our data are consistent with a model
in which PAKa phosphorylates and thereby inhibits the
activity of MHC-PKC and possibly MHCKA. According
to such a model, this posterior localization of PAKa would
allow MHCK-mediated disassembly of myosin II fibers at
the leading edge while inhibiting the disassembly of myo-
sin II fibers at the posterior. Myosin II light chain kinases
are not likely to be substrates of PAKa, since light chain
phosphorylation controls myosin II motor activity and not
its assembly (Griffith et al., 1987; Chen et al., 1995; Smith
et al., 1996). Our results are consistent with the finding
that cells expressing a myosin II mutant in which the three
mapped MHC-PKC phosphorylation sites are converted
to Ala do not maintain their shape and are unable to sup-
press the formation of lateral pseudopodia (Stites et al.,
1998). Thus, the ability to sequentially assemble and disas-
semble myosin II, possibly in response to the activation
and adaptation of PAKa kinase activity, appears to be crit-
ical for cell movement.
Dictyostelium PAKa has high homology to Dictyoste-
lium MIHCK. In Acanthamoeba and Dictyostelium, PAK
homologues phosphorylate myosin I heavy chain and stim-
ulate the Mg21-dependent ATPase activity (Lee et al.,
1996; Brzeska et al., 1997). Immunohistochemical studies
demonstrate that three classic myosin Is, myoI-B, myoI-C,
and myoI-D, are concentrated at the leading edge of
chemotaxing cells (Jung et al., 1993; Morita et al., 1996),
and are not found in the cleavage furrow, suggesting that
myosin Is are not PAKa substrates.
PAKs have been implicated in the morphological
changes resulting from changes in the actin cytoskeleton
associated with Rac and Cdc42 (Knaus and Bokoch, 1998).
Microinjection of activated PAK1 protein into quiescent
Swiss 3T3 cells induces the rapid formation of lamellipo-
dia, filopodia, and membrane ruffles (Sells et al., 1997),
which is very similar to the effect of microinjection of acti-
vated Rac and Cdc42. The interaction between the pro-
line-rich domain of PAK1 and a protein containing an
SH3 domain appears to be important for regulating PAK1
activity. Nck, an adapter protein containing SH2 and SH3
domains, binds PAK1 and induces PAK1 relocalization to
the membrane, leading to its activation (Lu et al., 1997).
Other studies demonstrate that localization of PAK to
membranes stimulates the kinase activity of PAK (Bo-
koch et al., 1996; Daniels et al., 1998) and our data with
myrPAKa are consistent with this model. Although we did
not examine whether the proline-rich domain of PAKa in-
teracts with proteins containing an SH3 domain such as
Nck, PAKa probably associates with an SH3 domain via
the PPxP sequence, resulting in the localization of PAKa
to the cortex. We note that PAKCA leads to a hyperpoly-
merization of actin. We do not know if this is a direct ef-
fect of PAKa on regulators of the actin cytoskeleton or is
indirect through the control of myosin II. It is also possible
that the PAKa kinase domain, when expressed by itself,
may not show the same level of substrate specificity as
the whole protein. Our observation that the expression of
myrPAKa results in a hyperpolymerization of myosin and
actin along the periphery of the cell, reinforces the model
that the subcellular localization of PAKa to the posterior
of the cell may be essential for its proper function. We sug-
gest that this overexpression along the entire membrane
or the localization by the myristoylation leads to a consti-
tutive activation of the kinase.
Although we have not demonstrated that PAKa is di-
rectly regulated by Rac1 and/or Cdc42, the GTP-bound,
but not GDP-bound, forms of Rac1B and HsCdc42 bind to
the PAKa CRIB domain. These data are consistent with,
but do not prove, that PAKa is a bone fide PAK. In con-
trast to the kinase domain alone, overexpression of the
entire PAKa protein or the kinase and CRIB domains
(PAKmG1K) does not cause a major change in the actin or
myosin cytoskeleton. This finding is consistent with obser-
vations of mammalian PAKs in which the CRIB domain
and an adjacent domain negatively regulate PAK kinase
activity (Sells et al., 1997). We expect that binding of acti-
vated Rac or Cdc42 to the CRIB domain of PAK regulates
the activation of the kinase, whereas the more NH2-termi-
nal domain regulates PAKa’s localization.
Cells overexpressing PAKa exhibit an upregulated as-
sembly of F-actin, resulting in multiple actin-enriched
crowns, which is very similar to the F-actin organization of
cells expressing Rac1BQ61L or of null cells of the Rac1
GAP, DdRacGAP1 (Chung, C.Y., S. Lee, C. Briscoe, and
R.A. Firtel, manuscript submitted for publication). These
similarities of F-actin organization suggest PAKa may be
important in regulating F-actin organization (Manser et al.,
1997; Sells et al., 1997). A Dictyostelium Ste20 family kinase
that phosphorylates severin, a Ca21-dependent F-actin
fragmenting protein, was purified and cloned recently
(Eichinger et al., 1998), indicating a direct signal transduc-
tion from the plasma membrane to the cytoskeleton by
phosphorylating actin-binding proteins. PAKa might con-
trol F-actin organization by phosphorylation of actin bind-
ing or actin-bundling proteins. The identification of the
downstream substrates of PAKa and the determination of
the role of phosphorylation by PAKa in regulating the
function of the substrate should resolve these issues.
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